Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sulfasalazine: I. An historical perspective.

× No keyword cloud information.

12 in total

Review 1. Sulphasalazine in ulcerative colitis: in memoriam?

Authors: J Hayllar; I Bjarnason
Journal: Gut Date: 1991-05 Impact factor: 23.059

2. N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Authors: Robert C Miller; Daniel G Petereit; Jeff A Sloan; Heshan Liu; James A Martenson; James D Bearden; Ronald Sapiente; Grant R Seeger; Rex B Mowat; Ben Liem; Matthew J Iott; Charles L Loprinzi
Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-23 Impact factor: 7.038

3. Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

Authors: M N Aparicio-Pagés; H W Verspaget; J C Hafkenscheid; G E Crama-Bohbouth; A S Peña; I T Weterman; H W Lamers
Journal: Gut Date: 1990-09 Impact factor: 23.059

Review 4. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors: S B Hanauer; G Stathopoulos
Journal: Drug Saf Date: 1991 May-Jun Impact factor: 5.606

Review 5. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors: Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal: Nat Rev Microbiol Date: 2016-03-14 Impact factor: 60.633

6. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Authors: P Miner; S Hanauer; M Robinson; J Schwartz; S Arora
Journal: Dig Dis Sci Date: 1995-02 Impact factor: 3.199

Sulfasalazine: I. An historical perspective.

Review 1. Sulphasalazine in ulcerative colitis: in memoriam?

2. N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

3. Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

Review 4. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Review 5. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

6. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Review 7. Understanding and modulating mammalian-microbial communication for improved human health.

8. [Significance of galenic preparations for luminal release of 5-aminosalicylic acid in human small intestinal lumen].

9. Treatment of non-steroidal anti-inflammatory drug induced enteropathy.

Review 10. Clinical pharmacokinetics of slow-acting antirheumatic drugs.